Skip to main content

Protagen Closes Round of Financing

NEW YORK (GenomeWeb News) – Dortmund, Germany-based Protagen said today that it has closed a new round of financing with existing institutional investors MIG, S-Venture Capital Dortmund, and Kreditanstalt für Wiederaufbau.
 
The firm did not disclose how much money it raised in the financing, but said it would use proceeds to strengthen and expand its UNIarray technology position and development of diagnostics. The UNIarray is a platform for diagnostics based on autoantibody patterns, and is also used in companion diagnostics and patient stratification for clinical studies, the firm said.
 
The firm is working on tests for prostate cancer, multiple sclerosis, rheumatoid arthritis, juvenile idiopathic arthritis, Morbus Parkinson, and Alzheimer’s disease.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.